BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT

CME Group (CME) Earnings: 4Q22 Key Numbers

CME Group Inc. (NASDAQ: CME) reported revenue of $1.2 billion for the fourth quarter of 2022, up 5% year-over-year. Net income attributable to shareholders was $630 million, or $1.75 per share, compared to $613.3 million, or $1.71 per share, last year. Adjusted EPS was $1.92. Average daily volume (ADV) was 21.8 million contracts, up 6% versus last […]

$CME February 8, 2023 1 min read

CME Group Inc. (NASDAQ: CME) reported revenue of $1.2 billion for the fourth quarter of 2022, up 5% year-over-year.

Net income attributable to shareholders was $630 million, or $1.75 per share, compared to $613.3 million, or $1.71 per share, last year. Adjusted EPS was $1.92.

Average daily volume (ADV) was 21.8 million contracts, up 6% versus last year.

ADVERTISEMENT